Advanced search
Publication Cover
Postgraduate Medicine Volume 130, 2018 - Issue 7
Submit an article Journal homepage
180
Views
6
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Cost-effectiveness of pharmaceutical care on patients undergoing maintenance hemodialysis – a multicenter randomized controlled study

Uday Venkat MatetiDepartment of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Mahe, Manipal, India;Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Deralakatte, Mangaluru, IndiaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-8149-2067View further author information
ORCID Icon,
Anantha Naik NagappaDepartment of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Mahe, Manipal, IndiaView further author information
,
Ravindra Prabhu AtturDepartment of Nephrology, Kasturba Medical College, Kasturba Hospital, MAHE, Manipal, IndiaView further author information
,
Shankar Prasad NagarajuDepartment of Nephrology, Kasturba Medical College, Kasturba Hospital, MAHE, Manipal, IndiaView further author information
&
Dharshan RangaswamyDepartment of Nephrology, Kasturba Medical College, Kasturba Hospital, MAHE, Manipal, IndiaView further author information
Pages 621-626 | Received 21 Apr 2018, Accepted 23 Jul 2018, Published online: 02 Aug 2018

References

  • Modi GK, Jha V. The incidence of end-stage renal disease in India: a population-based study. Kidney Int. 2006;70(12):2131–2133.
  • Kher V. End-stage renal disease in developing countries. Kidney Int. 2002;62(1):350–362.
  • Jha V. Current status of end-stage renal disease care in India and Pakistan. Kidney Int. 2013;3(1):157–160.
  • Jha V. End-stage renal care in developing countries: the Indian experience. Renal Fail. 2004;26(3):201–208.
  • Jha V. Current status of end-stage renal disease care in south Asia. Ethn Dis. 2009;19(1):S1–27–32.
  • Manley HJ, Garvin CG, Drayer DK, et al. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant. 2004;19(7):1842–1848.
  • Manley HJ, McClaran ML, Overbay DK, et al. Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis. 2003;41(2):386–393.
  • Sathvik BS, Mangasuli S, Narahari MG, et al. Medication knowledge of hemodialysis patients and influence of clinical pharmacist provided education on their knowledge. Indian J Pharm Sci. 2007;69(2):232–239.
  • Jeloka T, Toraskar D, Sanwaria P, et al. Regular monthly prescription with knowledge of each medicine may improve drug adherence in hemodialysis patients. Indian J Nephrol. 2014;24(2):131–132.
  • Sathvik BS, Parthasarathi G, Narahari MG, et al. An assessment of the quality of life in hemodialysis patients using the WHOQOL-BREF questionnaire. Indian J Nephrol. 2008;18(4):141–149.
  • Nasution A, Sulaiman SSA, Shafie AA. Cost-effectiveness of clinical pharmacy education on infection management among patients with chronic kidney disease in an Indonesian hospital. Value Health Reg Issues. 2013;2(1):43–47.
  • Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–543.
  • Mateti UV, Nagappa AN, Bairy M, et al. Pharmaceutical care for dialysis patients. Syst Rev Pharm. 2013;4(1):1–6.
  • Mateti UV, Nagappa AN, Attur RP, et al. Impact of pharmaceutical care on the health-related quality of life among hemodialysis patients–a multicenter randomized controlled study. Saudi J Kidney Dis Transpl. 2017;28(6):1293–1306.
  • Mateti UV, Nagappa AN, Attur RP, et al. Preparation, validation and user-testing of pictogram-based patient information leaflets for hemodialysis patients. Saudi Pharm J. 2015;23(6):621–625.
  • Mateti UV, Nagappa AN, Attur RP, et al. Cross-cultural adaptation, validation and reliability of the South Indian (Kannada) version of the kidney disease and quality of life (KDQOL-36) instrument. Saudi J Kidney Dis Transpl. 2015;26(6):1246–1252.
  • Prieto L, Sacristán JA. Problems and solutions in calculating quality-adjusted life years (QALYs). Health Qual Life Out. 2003;1:80.
  • Chuang LH, Whitehead SJ. Mapping for economic evaluation. Br Med Bull. 2012;101:1–15.
  • Abraham S, Venu A, Ramachandran A, et al. Assessment of quality of life in patients on hemodialysis and the impact of counseling. Saudi J Kidney Dis Transpl. 2012;23(5):953–957.
  • Rascati KL. Essentials of pharmacoeconomics: cost-effectiveness analysis. Philadelphia: Lippincott Williams & Wilkins; 2014.
  • World Health Organization Global Health Expenditure database: Out-of-pocket health expenditure (% of total expenditure on health). [cited 2018 Apr 1]. Available from: https://data.worldbank.org/indicator/SH.XPD.OOPC.TO.ZS
  • Jha V, Chugh KS. Dialysis in developing countries: priorities and obstacles. Nephrology. 1996;2(2):65–72.
  • Ballal HS. The burden of chronic kidney disease in a developing country, India. DaVita’s Clin J Nephrologists. 2007;9:12–19.
  • Mani MK. The management of end stage renal disease in India. Artif Organs. 1998;22(3):182–186.
  • Wyld M, Morton RL, Hayen A, et al. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med. 2012;9(9):e1001307.
  • Manley HJ, Carroll CA The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Sem Dialysis. 2002; 15(1):45–49.
  • Rubio-Valera M, Bosmans J, Fernandez A, et al. Cost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR Study). PloS One. 2013;8(8):e70588.
  • Marseille E, Larson B, Kazi DS, et al. Thresholds for the cost–effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015;93(2):118–124.
  • India GDP per Capita. [cited 2018 Apr 10]. Available from: https://www.ceicdata.com0/en/indicator/india/gdp-per-capita

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.